Results 71 to 80 of about 1,131 (155)

Libretto

, 2015
https://ir.lib.uwo.ca/disc_image_gallery/1005/thumbnail ...
openaire   +2 more sources

UNE PERSPECTIVE SÉMANTIQUE INTÉGRALISTE SUR L’INTERFÉRENCE TEXTE-MUSIQUE DANS LE CAS DU THÉÂTRE MUSICAL

Studia Universitatis Babeş-Bolyai. Musica, 2014
The present article focuses its investigation on the place of direct and private interference of the literary text with mu100sic, being consequently dedicated to the “semantic-integralist” analysis reguarding a complete cultural-artistic object which is
Mirona BENCE-MUK
doaj  

Real-world external control arm for the single-arm LIBRETTO-001 trial of selpercatinib in RET-mutation-positive medullary thyroid cancer: RECALIB-RET. [PDF]

ESMO Open
Hadoux J, Hernando J, Wong KH, Do Cao C, Lasolle H, Buffet C, Benisvy D, Illouz F, Schneegans O, Varnier R, Drui D, Zanetta S, Hescot S, Muller M, Nascimento C, Roudaut N, Khanal M, Zheng S, Li X, Singh R, Tian W, Afonso AS, Houot B, Borget I, Segall G.   +24 more
europepmc   +1 more source

Acute β-cell failure induced by selpercatinib in RET fusion-positive non-small cell lung cancer: A case report. [PDF]

Respir Med Case Rep
Tsukao H, Kojima R, Nakanishi S, Miyanishi Y, Fujii Y, Yamaguchi W, Nakaya J, Kojima T.   +7 more
europepmc   +1 more source

DNA and RNA-based next-generation sequencing for companion diagnostic rearrangement detection in solid tumors. [PDF]

Oncologist
Keller-Evans RB, Lee JK, Allen JM, Zhong L, Gjoerup O, Ross JS, Gascó A, Huang RSP.   +7 more
europepmc   +1 more source

Comparative Effectiveness of First-Line Selpercatinib versus Standard Therapies in Patients with RET-Activated Cancers: An Exploratory Interpatient Analysis of LIBRETTO-001. [PDF]

Cancers (Basel), 2023
De Braud F, Deschler-Baier B, Morris JC, Worden F, Han Y, Kiiskinen U, Jen MH, Barker SS, Szymczak S, Gilligan AM.   +9 more
europepmc   +1 more source

Advancing <i>RET</i>-targeted therapy in thyroid cancer: insights and implications from the LIBRETTO-001 study. [PDF]

Transl Cancer Res
Baek HS, Lim DJ.
europepmc   +1 more source

Correction to: Long-term safety of selpercatinib for Rearranged during transfection (RET)-activated advanced solid tumors in LIBRETTO-001: differing patterns of adverse events over time. [PDF]

Oncologist
europepmc   +2 more sources

Matching-adjusted indirect comparison of selpercatinib and pralsetinib in <i>RET</i> fusion-positive non-small cell lung cancer. [PDF]

Future Oncol
Hochmair M, Kiiskinen U, D'yachkova Y, Puri T, Wang X, Wolowacz S, Vickers A, Nadal E.   +7 more
europepmc   +1 more source

Preoperative selpercatinib induces major pathological response in a patient with stage IIIA, RET fusion-positive non-small cell lung cancer: A case report. [PDF]

Medicine (Baltimore)
Breitenecker K, Fabikan H, Weinlinger C, Krenbek D, Klikovits T, Watzka S, Valipour A, Hochmair MJ.   +7 more
europepmc   +1 more source